Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine reversal of remifentanil-induced respiratory depression in healthy volunteers
NL-OMON24921Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Oct 2016
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of esketamine and remifentanil in opioid-induced respiratory depression (OIRD) (3 arms), sponsored by Leiden University Medical Center. Started Oct 2016; status: recruiting.
02
Drugs
esketamineremifentanil
03
Conditions
opioid-induced respiratory depression (OIRD)
Beyond the preview
Go deeper on NL-OMON24921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24921.